Answers are grounded in this paper and cite their sources.
FPR is expressed by highly malignant human glioma cells and appears to mediate motility, growth, and angiogenesis of human glioblastoma by interacting with host-derived agonists. Thus, FPR may represent a molecular target for the development of novel antiglioma therapeutics.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: